Journal of Rheumatic Diseases

Table. 3.

Comparison between Fibromyalgia patients with mild tinnitus and moderate-to-severe tinnitus

Severity of tinnitus Tinnitus grade 1∼2 (n=12)* Tinnitus grade 3∼5 (n=8)* p-value
Age (yr) 55.2±7.5 53.2±13.0 0.666
Sex 0.209**
Male 0 (0)ㅤ 1 (12.5)
Female 12 (100) 7 (87.5)
Fibromyalgia duration (mo) 81.7±63.7 98.3±58.7 0.561
Tinnitus duration (mo) 46.8±43.0 111.6±119.5 0.178
Tinnitus side 0.303**
Left side 1 (8.3) 0 (0)
Right side 6 (50.0) 2 (25.0)
Both sides 5 (41.7) 6 (75.0)
Widespread Pain Index 10.8±4.5 14.1±6.4 0.192
Symptom Severity Score 7.6±2.0 8.8±1.9 0.206
VAS of pain 70.8±13.8 80.6±20.1 0.211
Fibromyalgia Impact Questionnaire 63.6±11.9 78.6±15.6 0.025
Insomnia Severity Index 13.9±5.9 17.8±5.4 0.160
SF-36
Physical functioning 43.3±10.5 21.9±17.3 0.003
Role limitation due to physical condition 25.0±28.2 15.6±35.2 0.517
Bodily pain 37.9±20.0 24.1±19.8 0.107
General health 30.4±9.4 23.8±14.3 0.223
Vitality (energy and fatigue) 30.4±14.4 18.8±9.2 0.058
Social functioning 55.2±20.3 34.4±19.8 0.035
Role limitation due to emotional condition 47.2±48.1 25.0±46.3 0.318
Mental health 49.3±16.7 29.0±17.6 0.017
Health change 31.3±28.5 12.5±13.3 0.065
Associated symptoms
Headache 11 (91.7) 7 (87.5) 1**
Irritable bowel syndrome 1 (8.3) 4 (50.0) 0.109**
Used medication§ 6 (50.0) 8 (100) 0.042**

Values are presented as mean±standard deviation or number (%). SF-36: Short-form Health Survey. *Tinnitus grade was calculated using the Tinnitus Handicap Questionnaire. The Visual Analog Scale (VAS) of pain intensity is a 100-point linear gauge in which 0=no pain and 100=worst pain imaginable. Satisfies the Rome IV diagnostic criteria. §Medication including selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor/Pregabalin. t-test; Mann–Whitney U-test; **chi-square test.

J Rheum Dis 2021;28:31~37 https://doi.org/10.4078/jrd.2021.28.1.31
© J Rheum Dis